New York S06937 requires insurance carriers to cover abuse-deterrent opioid medications.
New York S06937 amends the insurance law to mandate that insurance carriers and health plans cover at least one abuse-deterrent opioid analgesic drug product per opioid analgesic active ingredient. The bill ensures that cost-sharing for these products does not exceed that of non-abuse deterrent opioids. It prohibits increasing patient cost-sharing or disincentives for prescribers or dispensers to comply with the law. Prior-authorization requirements or other utilization review measures cannot mandate the use of non-abuse deterrent opioids to access abuse-deterrent ones.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.